IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 25 to 36 of 481

8 July 2024

Reforming drug laws to address racial injustice - Submission to the UN Committee on the Elimination of Racial Discrimination (CERD)

Release, Amnesty International, UNJUST UK, HRI and IDPC shed light on racial disparities in drug policing and associated human rights violations, urging for decriminalisation, the redirection of resources into care systems, and equitable reform.

25 June 2024

LGBTQI+ people who use drugs in Thailand: Advocacy for improved health and human rights responses

APCOM and IDPC urge the public, law enforcement, and policymakers in Thailand to help ensure equality and equity for LGBTQ+ people who use drugs, especially in their access to health and social services, and ending stigma and discrimination against them.

30 May 2024

IDPC contribution to the Global Coalition to Address Synthetic Drug Threats

IDPC recommends improving data collection, prioritising health-based responses, reviewing drug policy frameworks and ensuring robust civil society engagement.

29 May 2024

National stakeholder dialogue: Towards a stigma reduction roadmap for people who use drugs in Ghana

UNAIDS Ghana and IDPC bring together key actors to identify priorities for tackling stigma surrounding people who use drugs, including education, training, and policy reform.

16 April 2024

Decriminalising drug use and sex work to end the criminalisation of poverty and homelessness - Submission to the UNSRs on the right to adequate housing and on extreme poverty and human rights

IDPC and other organisations encourage the Special Rapporteurs to acknowledge the harmful effects of criminalising drug use and sex work in relation to the policing of people living in poverty in public spaces.

9 April 2024

For a drug policy that makes Europe safer, healthier, and more just - Drug policy manifesto for the 2024 European Parliament elections

Over 30 European organisations acknowledge the failure of drug policies and demand a new approach prioritising health, rights, and community participation

4 April 2024

Breaking Barriers and Building Bridges: Navigating justice for womxn who use drugs in Southeast Asia

IDPC, HON, IDUCARE and SPINN outline barriers faced by women who use drugs in realising their health and right, showcases good practices of care and support, and proposes recommendations for reform.

11 March 2024

3rd Brandenburg Forum (BBF) in Geneva: Consolidating progress for human rights in drug policy - Meeting report

This meeting report summarises key debates and interventions, and provides an account of the priorities identified by participants.

23 January 2024

Analysis of the World Drug Report 2023: The promise and peril of going green

IDPC, Viso Mutop and GDPO explore the report's discussion of buoyant drug markets and UNODC's stance on key issues like decriminalisation, human rights and environmental impact, noting the growing influence of green criminology and its potential to reshape perspectives.

13 December 2023

IDPC Progress Report 2022-2023

IDPC summarises key wins and progress achieved between April 2022 and March 2023 toward ensuring that social justice and human rights are core tenets of drug policies.

4 December 2023

Off track: Shadow report for the mid-term review of the 2019 Ministerial Declaration on drugs

IDPC draws on wide-ranging data from UN, government, academic and civil society sources to conclude that there has been little, incomplete or no progress in achieving the goals set out in the 2019 Ministerial Declaration on Drugs.

4 December 2023

8th Brandenburg Forum on Drugs and Development Policies report - 'The way forward to 2029: Accelerating progress in global drug policies'

The Forum addressed development, public health, human rights, and emerging trends in drug policies, with recommendations on decriminalisation, human rights and building support for change.